Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Breast Cancer Research : BCR|May 30, 2020
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancerFlorian Clatot, Anne Perdrix, Ludivine Beaussire, et al.
Frontiers in Oncology|November 28, 2022
Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancerAdrien Grancher, Ludivine Beaussire, Sylvain Manfredi, et al.
Clinical Chemistry|July 12, 2019
A Simple, Universal, and Cost-Efficient Digital PCR Method for the Targeted Analysis of Copy Number VariationsKévin Cassinari, Olivier Quenez, Géraldine Joly-Hélas, et al.
British Journal of Cancer|March 16, 2025
ctDNA variations according to treatment intensity in first-line metastatic colorectal cancerAdrien Grancher, Ludivine Beaussire-Trouvay, Virginie Vernon, et al.
British Journal of Cancer|August 4, 2017
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumoursDavid Sefrioui, France Blanchard, Emmanuel Toure, et al.
Molecular Cancer Therapeutics|March 31, 2019
Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal CancerLeslie Duplaquet, Martin Figeac, Frédéric Leprêtre, et al.
Oncotarget|November 2, 2016
Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitorFlorian Clatot, Anne Perdrix, Laetitia Augusto, et al.
International Journal of Cancer|December 23, 2016
Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancerDavid Sefrioui, Thomas Vermeulin, France Blanchard, et al.
British Journal of Cancer|June 11, 2021
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)David Sefrioui, Ludivine Beaussire, André Gillibert, et al.
Pageof 3